Not finding it? Sign in to also search OpenAlex live.
-
A first-in-human phase 1 dose escalation study of spartalizumab (PDR001), an anti–PD-1 antibody, in patients with advanced solid tumors2020 Journal for ImmunoTherapy of Cancer article Medicine Cancer Immunotherapy and Biomarkers Open access cited by 1 patent
Aung Naing, Justin F. Gainor, Hans A. J. Gelderblom, Patrick M. Forde, Marcus Otho Butler, Chia‐Chi Lin, +11 more
86citations -
Safety and immunogenicity of co-administered hookworm vaccine candidates Na-GST-1 and Na-APR-1 in Gabonese adults: a randomised, controlled, double-blind, phase 1 dose-escalation trial2020 The Lancet Infectious Diseases article Immunology and Microbiology Parasites and Host Interactions Open access
Ayôla Akim Adégnika, Sophia G. de Vries, Yabo Josiane Honkpéhèdji, Jean Claude Dejon Agobe, Kafui G Vodonou, Rodrigue Bikangui, +24 more
57citations -
A phase I, randomized, double‐blind, placebo‐controlled, single‐ and multiple dose escalation study evaluating the safety, pharmacokinetics and pharmacodynamics of VX‐128, a highly selective Nav1.8 inhibitor, in healthy adults
Hemme J. Hijma, Emilie M.J. van Brummelen, Pieter S. Siebenga, Geert Jan Groeneveld
19citations -
Safety and immunogenicity of the co-administered Na-APR-1 and Na-GST-1 hookworm vaccines in school-aged children in Gabon: a randomised, controlled, observer-blind, phase 1, dose-escalation trial2024 The Lancet Infectious Diseases article Immunology and Microbiology Parasites and Host Interactions Open access
Jeannot Fréjus Zinsou, David Joseph Diemert, Jean Claude Dejon Agobe, Bayodé Roméo Adégbitè, Yabo Josiane Honkpéhèdji, Kafui G Vodonou, +12 more
17citations -
Viral clearance, pharmacokinetics and tolerability of ensovibep in patients with mild to moderate COVID‐19: A phase 2a, open‐label, single‐dose escalation study2022 British Journal of Clinical Pharmacology article Medicine SARS-CoV-2 and COVID-19 Research Open access
Manon L. M. Prins, Johan L. van der Plas, Maurits F. J. M. Vissers, Cécile L. Berends, Gaby Tresch, Marianne Soergel, +10 more
10citations -
476P First-in-human, dose-escalation phase I trial of intratumoral (IT) CyPep-1 in patients (pts) with advanced solid tumors2022 Annals of Oncology article Medicine Cancer Immunotherapy and Biomarkers Open access cited by 1 patent
F. A. L. M. Eskens, F. Opdam, E. Gort, H. Gelderblom, L. Prestegarden, C. Pico-Navarro
4citations -
SAT0104 MAINTENANCE OF SDAI REMISSION AND PATIENT-REPORTED OUTCOMES (PROS) FOLLOWING DOSE DE-ESCALATION OF ABATACEPT IN MTX-NAÏVE, ANTI-CITRULLINATED PROTEIN ANTIBODY (ACPA)+ PATIENTS WITH EARLY RA: RESULTS FROM AVERT-2, A RANDOMISED PHASE IIIB STUDY2020 Annals of the Rheumatic Diseases article Medicine Rheumatoid Arthritis Research and Therapies Open access
Paul E. Emery, Yoshiya Tanaka, Vivian P. Bykerk, Tom W. J. Huizinga, Gustavo Citera, C.O. Bingham, +8 more
1citations -
ESTRO consensus guidelines on GTV delineation and dose-escalation in rectal cancer2026 Clinical and Translational Radiation Oncology article Medicine Colorectal Cancer Surgical Treatments Open access
Giuditta Chiloiro, Angela Romano, Regina G. H. Beets‐Tan, Krzysztof Bujko, Davide Cusumano, Emmanouil Fokas, +10 more
0citations -
2417P De-escalation of therapy with androgen receptor pathway inhibitors or docetaxel by using PSMA PET/CT in metastatic castration-resistant prostate cancer patients: study results from a Dutch cohort2025 Annals of Oncology article Biochemistry, Genetics and Molecular Biology Prostate Cancer Treatment and Research Open access
Kim J. M. van der Velden, Sietse van Mossel, Fleur Kleiburg, Lioe‐Fee de Geus‐Oei, Tom van der Hulle, Malou C. P. Kuppen, +3 more
0citations -
De-escalation of axillary treatment in the event of a positive sentinel lymph node biopsy in cT1–2 N0 breast cancer treated with mastectomy: nationwide registry study (BOOG 2013-07)2024 British journal of surgery article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Sabine Rosalie de Wild, Lori M. van Roozendaal, Johannes H.W. de Wilt, Thijs van Dalen, Jos A. van der Hage, Frederieke H van Duijnhoven, +14 more
17citations -
1128P A phase I dose escalation and expansion study of FHD-286, a novel BRG1/BRM (SMARCA4/SMARCA2) inhibitor, for the treatment of metastatic uveal melanoma
Sapna Pradyuman Patel, Meredith Ann McKean, S. Piperno-Neumann, Alexander Noor Shoushtari, Leonel Fernando Hernandez-Aya, Marlana M. Orloff, +11 more
6citations -
1176P Open-label, dose escalation, phase I/II study to assess safety, tolerability, immunogenicity and preliminary clinical activity of the therapeutic cancer vaccine PDC*lung01 with or without anti-programmed death-1 (PD-1) treatment in patients with non-small cell lung cancer (NSCLC)2022 Annals of Oncology article Immunology and Microbiology Immunotherapy and Immune Responses Open access
J.F. Vansteenkiste, I. Demedts, E. Pons-Tostivint, B. Biesma, F. Borm, B. Colinet, +14 more
5citations -
1623MO Ripretinib intra-patient dose escalation (IPDE) following disease progression provides clinically meaningful progression-free survival (PFS) in gastrointestinal stromal tumor (GIST) in phase I study
Filip Jankú, Ping Chi, Michael Charles Heinrich, Margaret von Mehren, Robin L. Jones, Kristen N. Ganjoo, +9 more
4citations -
De-escalation of axillary treatment in case of a positive sentinel lymph node biopsy in cT1-2N0 breast cancer treated with mastectomy: a nationwide registry study to provide insight into prognosis2024 European Journal of Surgical Oncology article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Sabine De Wild, Lori van Roozendaal, Hans De Wilt, Thijs van Dalen, Jos A. van der Hage, Frederieke H van Duijnhoven, +14 more
0citations -
Prognostic value of histopathologic traits independent of stromal tumor-infiltrating lymphocyte levels in chemotherapy-naïve patients with triple-negative breast cancer2024 ESMO Open article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Leonora W. de Boo, Katarzyna Jóźwiak, Natalie D. ter Hoeve, P. J. van Diest, Mark Opdam, Yuwei Wang, +44 more
12citations